IRB Review of Changes to Previously Approved Research
During the course of study conduct, most research involving human participants will require some form of planned modification or revision.
During the course of study conduct, most research involving human participants will require some form of planned modification or revision.
The applications of mRNA-based therapies in cancer research represent one of the next groundbreaking steps toward improved cancer treatments. While
Explore the state of DE&I in clinical research with survey insights on diversity plans, budgeting efforts, and progress in trial representation.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
A phased approach to quality management systems (QMS) ensures quality is embedded at every stage, from discovery to post study.
Discover how Parexel accelerated mRNA study startups with Advarra’s integrated IRB and IBC reviews, achieving rapid timelines and budget goals.
A variety of distinctive ethical, regulatory, and legal challenges stand in the way of greater adoption of decentralized clinical trial (DCT) components and study designs.
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
When it comes to clinical development, precision, compliance, and quality assurance are paramount. Like any complex and highly regulated industry,
HRPP staffing is essential for maintaining research ethics, even with sIRB mandates streamlining review processes for multisite studies. Discover key HRPP roles and benefits.
Human research protection programs (HRPPs) play a critical role in protecting the rights, safety, and welfare of research participants. A
Single IRB (sIRB) review streamlines oversight for multisite trials, reducing administrative burdens while ensuring participant protections across all sites.